Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (89)

« Back to Publications

Engineering Genome-Free Bacterial Cells for Effective SARS-COV-2 Neutralisation.

Yin Y. et al, (2025), Microbial biotechnology, 18

The molecular reach of antibodies crucially underpins their viral neutralisation capacity

Huhn A. et al, (2025), Nature Communications, 16

Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: A prospective observational study in Vietnam

Thanh TT. et al, (2024), International Journal of Infectious Diseases, 147, 107173 - 107173

Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition

Asor R. et al, (2024), Proceedings of the National Academy of Sciences, 121

Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike.

Duyvesteyn HME. et al, (2024), Structure (London, England : 1993), 32, 1594 - 1602.e6

A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity

Liu C. et al, (2024), Cell Reports Medicine, 5, 101553 - 101553

Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection.

Liu C. et al, (2024), Nature communications, 15

The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.

Zhou D. et al, (2024), Nature communications, 15

Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses

Dijokaite-Guraliuc A. et al, (2023), Cell Reports, 42, 112271 - 112271

A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75

Huo J. et al, (2023), Cell Reports, 42, 111903 - 111903

Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection

Stuart D. et al, (2023)

Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum

Tuekprakhon A. et al, (2022), Cell, 185, 2422 - 2433.e13

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

Flaxman A. et al, (2021), The Lancet, 398, 981 - 990

The antigenic anatomy of SARS-CoV-2 receptor binding domain

Dejnirattisai W. et al, (2021), Cell, 184, 2183 - 2200.e22

Flavivirus maturation leads to the formation of an occupied lipid pocket in the surface glycoproteins

Renner M. et al, (2021), Nature Communications, 12

Load More

1
2
3
4
5
6